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The ability to introduce DNA into mammalian cells capsule, and the vascular endothelium and weakly ex-
pressed in the tubular epithelium. However, no delinea-in vitro has revolutionized the understanding of both nor-
tion of which intrarenal vascular compartments (for exam-mal physiology and pathophysiologic mechanisms of dis-
ple, cortical vs. medullary) was described. Additionally,ease. Although gene transfer in vitro has met with great
v integrins are aberrantly expressed in numerous neo-success, this has not been the case for in vivo studies.
plasms, including invasive glioblastomas, metastatic mel-The general lack of clinical efficacy has led to a critical
anomas, and renal carcinoma [9, 11, 12]. These character-evaluation of current generation vectors and has empha-
istics make v integrins an attractive target for genesized the need for improved gene transfer vectors. The
transfer strategies.replication incompetent human adenovirus is a vector
Filamentous bacteriophage peptide display librariessystem for which much is already known regarding struc-
have been used both in vitro and in vivo to identify peptideture and function. Specifically, adenoviral vectors have
sequences, which preferentially bind specific cell surfacebeen used to deliver genes to a number of tissues, includ-
receptors. Koivunen et al have used this system to isolateing vascular, lung, neuronal, and muscle tissues in vivo
a high-affinity peptide ligand to the v integrins [13].[1–4]. Advantages of adenoviral vectors include (1) the
This nine-amino acid cyclic peptide, ACDCRGDCFCG,ability to transfer genes into multiple cell types in differ-
contains the arginine glycine aspartate (RGD) integrin-ent species without the need for cell replication, (2) the
binding motif known to bind to the v integrins withability to produce high-titer stocks (1012 particles/mL),
approximately 100-fold higher affinity than the GRGDSPthus enabling highly efficient in vivo gene transfer, (3)
sequence from fibronectin. This bacteriophage intrave-acceptance of DNA fragments of up to approximately
nously injected preferentially homed to murine models28 kb and regulated expression of cDNAs, (4) relative
of malignant melanomas and breast carcinoma [14]. In
stability in the systemic circulation, and (5) safety. an effort to target adenoviral transfer to the v integrinsMany human tissues, including skeletal muscle, smooth of the vascular endothelium, we used a chimeric adeno-
muscle, endothelium, and kidney, have low-level adeno- viral vector [AdZ.F(RGD)] with this same RGD integrin
viral receptor expression, thus limiting adenoviral bind- binding motif incorporated into the C terminus of the
ing [5, 6]. Adenoviral gene transfer could be enhanced adenovirus fiber protein [15].
by targeting binding to receptors on specific cells or tis- We demonstrate that this modified adenoviral vector
sues of interest or targeting receptors, which are up- results in ligand-specific gene transfer to vascular endo-
regulated in specific diseases states. An example of this thelial cells in vitro. In vivo administration of the chime-
type of receptor is the v integrin. Integrins are trans- ric adenoviral vector into the renal artery of the rat
membrane glycoproteins involved in cell–cell and cell– resulted in significantly enhanced -galactosidase ex-
matrix interaction. The v integrins have been shown to pression in the vascular endothelium of the kidney com-
be present in the vascular endothelium in general, includ- pared with an adenoviral vector containing the native
ing the kidney specifically [7–9]. They are also up-regu- adenoviral fiber protein (AdZ). Additionally, the incor-
lated in the presence of basic fibroblast growth factor/ poration of the high-affinity peptide ligand into the ade-
vascular endothelial growth factor (bFGF/VEGF) [10]. noviral fiber knob resulted in a novel distribution of
Rabb et al evaluated human tissue kidney samples ob- transgene expression (renal cortex and the subcapsular
tained from patients undergoing nephrectomy to remove region) compared with AdZ.
a neoplastic lesion [9]. They found the v integrins to
be expressed in glomerular epithelial cells, Bowman’s GENE DELIVERY BY AdZ AND AdZ.F(RGD)
TO BOVINE ENDOTHELIAL CELLS
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Fig. 1. Specificity of AdZ and AdZ; F(RGD) transduction on endothelial cells. (A) Monolayers of HuVECs and human lung epithelial cells
(A549) in 24-well collagen-coated plates were incubated with 107, 108, or 109 virus particles of AdZ or AdZ.F(RGD) for 60 minutes followed by
removal of unbound particles. The cells were cultured for 48 hours followed by determination of -galactosidase activity for each sample using a
chemiluminescent assay. Results are the average of duplicate samples. (B) Monolayers of HuVECs in 24-well collagen-coated plates were
preincubated for 30 minutes with purified recombinant F5K or F5K(RGD) protein. The cells were further incubated with 109 virus particles of
AdZ or AdZ.F(RGD) for an additional 60 minutes, followed by removal of unbound particles. The cells were cultured for 48 hours followed by
determination of -galactosidase activity for each sample using a chemiluminescent assay. Results are the average of duplicate samples.
endothelial cells (HuVECs) and A549 cells (Fig. 1A). dominantly the outer stripe), as well as larger arterial
blood vessels in the cortex, with some staining in theHuVECs express the v integrins but low levels of adeno-
peritubular cortical capillaries [16].virus fiber receptor. A549 cells are human lung epithelial
The marked increased transduction efficiency of endo-cells. AdZ.F(RGD) specificity of binding to the fiber
thelial cells in vitro using AdZ.F(RGD) suggested thatreceptor or to v integrins was assessed through competi-
this vector might increase gene delivery to the vasculartion assays with soluble recombinant fiber protein. Pre-
endothelium of the kidney. To investigate this, we ini-incubation of HuVECs with either wild-type (F5K) or
tially infused 1 1011 particles of AdZ and AdZ.F(RGD)the chimeric soluble fiber protein [F5K(RGD)] resulted
and compared -galactosidase staining at 48-hours post-in markedly decreased -galactosidase activity of AdZ,
infusion. The dose chosen was significantly lower thanwhereas only the F5K(RGD) decreased -galactosidase
the standard 8  1011 particles used in prior studies withactivity of AdZ.F(RGD) (Fig. 1B). These results demon-
AdZ in an effort to accentuate any differences in effi-strate that transgene expression with AdZ.F(RGD) is
ciency of gene transfer. The kidney infused with AdZspecific to the incorporated peptide in this endothelial
revealed no staining (Fig. 2A), consistent with prior datacell line. In addition, compared with AdZ, the additional
at this dose (unpublished data). The same dose of AdZ.Finteraction of AdZ.F(RGD) with v integrins signifi-
(RGD) resulted in some -galactosidase staining of thecantly increased virus transduction in HuVECs, which
kidney (Fig. 2B). The right uninfused kidney shown inexpress little detectable fiber receptor. The increased
Figure 2 A and B revealed no -galactosidase staining,transduction of endothelial cells by AdZ.F(RGD) is
excluding the possibility that endogenous -galactosi-likely due to increased binding of the virus to v integrins
dase activity was being detected in the left kidney.expressed on these cells.
We then compared renal artery infusion of 8  1011
particles of both AdZ and AdZ.F(RGD), an amount that
INCREASED GENE DELIVERY TO has historically led to significant transgene expression in
THE VASCULATURE OF THE the kidney using the AdZ vector. On gross -galactosi-
KIDNEY BY AdZ.F(RGD) dase staining of the infused left kidney, AdZ (Fig. 3A, rat
To date, we have performed renal artery infusion of 22) resulted in transgene expression diffusely throughout
an adenoviral vector containing the native adenoviral the kidney, with the majority of staining in the outer
fiber protein in over 150 animals. Infusion of 8  1011 medulla consistent with historical controls. AdZ.F(RGD)
particles consistently resulted in -galactosidase staining yielded a marked increase in -galactosidase staining in
the cortical and subcapsular region of the kidney (Fig. 3B,primarily in the vasculature of the outer medulla (pre-
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Fig. 2. Comparison of in vivo transduction of
AdZ and AdZ.F(RGD) with low-dose renal
artery infusion. Low-dose (1  1011 particles)
AdZ (N  3) and AdZ.F(RGD) (N  4) was
infused into the left renal artery and allowed
to incubate in the left kidney for 45 minutes
at 4C. Both the left and the right kidney was
harvested at 48 hours and stained for -galac-
tosidase activity. The right kidney serves as
an internal negative control. (A) Gross slice
of the left kidney with AdZ (3). (B) Gross
slice of the left kidney infused with AdZ.F
(RGD) (3).
Fig. 3. Comparison of in vivo transduction of
AdZ and AdZ.F(RGD) with standard dose
renal artery infusion. Standard dose (8  1011
particles) AdZ (N  3) and AdZ.F(RGD)
(N  4) was infused into the left renal artery
and allowed to incubate in the left kidney for
45 minutes at 4C. Kidneys were harvested
at 48 hours and stained for -galactosidase
activity. The right kidney serves as an internal
negative control. (A) A gross slice of the left
kidney infused with AdZ (3). (B) A gross
slice of the left kidney infused with AdZ.F
(RGD) (3). (C ) Macroscopic view of a 12
m histologic section of AdZ (3.2). (D)
Macroscopic view of 12 m histologic section
of AdZ.F(RGD) (3.2). (E ) Microscopic
view of a 12 m histologic section of AdZ
(25). (F ) Microscopic view of a 12 m histo-
logic section of AdZ.F(RGD) (25). (G)
High-power microscopic view of a 6 m histo-
logic section of AdZ.F(RGD) (40).
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Fig. 4. In vivo competition assay with RGD and RGE peptides. Soluble RGD and RGE peptides (1.0 mg/mL) were coinfused with 8  1011
particles of AdZ.F(RGD) prior to renal artery infusion. (A) Left kidney -galactosidase staining in the left kidney following coinfusion of the
RGD peptide (25). (B) Coinfusion of the control RGE peptide (25).
rat 6) compared with AdZ. Macroscopic evaluation of or RGE peptides (1.0 mg/mL) were coinfused with the
8  1011 particles of AdZ.F(RGD). The RGD peptide12.0 m sections of AdZ (Fig. 3C, rat 22) and AdZ.F
(RGD) (Fig. 3D, rat 6) stained for-galactosidase clearly markedly decreased -galactosidase staining and spe-
cifically abolished the enhanced -galactosidase stainingdemonstrated both the increased transgene expression
and importantly the novel cortical and subcapsular dis- seen in the renal cortex (Fig. 4A). In contrast, when the
control RGE peptide was coinfused with AdZ.F(RGD),tribution of transgene expression associated with AdZ.F-
(RGD) compared with AdZ. Higher power microscopic the -galactosidase staining was similar to AdZ.F(RGD)
alone (Fig. 4B). Thus, the ablation of transgene expres-evaluation of AdZ (Fig. 3E, fat 22) and AdZ.F(RGD)
(Fig. 3F, rat 6) corroborated the increased transduction sion, with the administration of the competitive cyclic
RGD peptide, suggests that the addition of the RGDefficiency of AdZ.F(RGD) compared with AdZ, but also
revealed that transgene expression with both vectors is peptide to the adenoviral vector resulted in specific in
vivo tropism.in the vascular endothelium. This difference was quanti-
tated by counting the number of cells, which show
-galactosidase positivity/cm2 in four random areas in
CONCLUSIONS
the renal cortex and medulla. The kidney infused with
We have demonstrated that a high-affinity peptideAdZ contained 6 cells/cm2  1.25 in the cortex and 6.75
ligand can be incorporated into the adenoviral fiber,cells/cm2  1.18 in the outer medulla. The kidney infused
resulting in ligand-specific gene transfer in endothelialwith AdZ.F(RGD) contained 15 cells/cm2  3.30 in the
cells in vitro. Infusion of this chimeric adenoviral vectorcortex for the kidneys infused with AdZ.F(RGD) and
into the renal artery of the rat not only yielded signifi-3.0 cells/cm2  0.577 in the outer medulla. These data
cantly enhanced transgene expression compared with ademonstrate a significant increase in transgene expres-
vector with the native adenoviral fiber but also a novelsion of AdZ.F(RGD) compared with AdZ in both the
distribution of transgene expression in vivo. Further-renal cortex (P  0.043) and medulla (P  0.029) and
more, this gene transfer in vitro and in vivo was specifi-demonstrate highly efficient gene transfer into the fine
cally blocked by the coadministration of a competitiveperitubular capillary cortical bed [6 m section for
antagonist.AdZ.F(RGD); Fig. 3G, rat 6]. Glomerular and tubular
To date, the scope of disease processes that can becells revealed no transgene expression.
addressed with adenoviral vectors has been limited by
either inefficient gene transfer or the inability to transfer
IN VIVO CYCLIC PEPTIDE COMPETITION ASSAY genes to specific tissues or cells of interest. The observa-
tion that a high-affinity peptide motif incorporated ontoTo confirm that the increased transgene expression
noted was due to the addition of the cyclic RGD peptide the C terminal of the adenoviral fiber can increase adeno-
viral transgene expression preferentially to a specific cellto the adenoviral fiber, we performed in vivo competi-
tion assays in the presence of synthetic RGD (GPen- type in vitro and in vivo will encourage the development
of additional adenoviral vectors with novel targetingGRGDSPCA) or control RGE (GRGESP) peptides
(GIBCO, BRL, Grand Island, NY, USA). Either RGD specificity.
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